Adverse event profile differences among long-acting gonadotropin-releasing hormone analogs: A real-world, pharmacovigilance study.

PLoS One · 2025 · PMC12250665 · PMID 40644420

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The reports of Long-acting GnRHa were submitted with an increasing trend year by year, mainly from 2019 to 2023 ( Fig 3A ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.